Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07298382 · ClinicalTrials.gov registry record · NA

See the Impact Beem's Blue Light Therapy Has on Your Skin Health!

A NA study of Skin, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07298382: Recruiting NA study of Skin, sponsored by Efforia.

NCT07298382 is a NA study of Skin that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, above the 47-participant average among 5 other Skin trials with a reported enrollment target (113% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07298382, a NA study of Skin, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing with deeply nourishing infrared light. This unique protocol is designed to help unlock healthier-looking skin and boost your natural glow.

Primary Outcome

The Comprehensive Weekly Skin Health Self-Assessment is designed to meticulously evaluate various aspects of skin health, including clarity, breakouts, pore size, redness, moisture, sensitivity, and signs of aging. This detailed survey allows individuals to track changes weekly, providing insights into the effectiveness of their skincare routines and the impact of lifestyle choices on their skin's condition. By regularly monitoring a wide range of skin health indicators, users can make informed

Conditions Studied

Interventions

  • DEVICE Blue Light Therapy

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-06
Est. Completion 2026-10-06
Phase NA
Efforia

19 total trials

What NCT07298382 shows while recruiting

NCT07298382 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 47-participant average among 5 other Skin trials with a reported enrollment target (113% higher).

The record links to 1 condition, with Skin appearing as the primary indexed condition, and to 1 intervention - of which Blue Light Therapy is the first listed.

NCT07298382 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07298382 about?

NCT07298382 is a clinical study titled "See the Impact Beem's Blue Light Therapy Has on Your Skin Health!". Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing wit...

What is the current status of trial NCT07298382?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-06. Estimated completion is 2026-10-06.

What conditions does trial NCT07298382 study?

This clinical trial studies the following conditions: Skin.

What interventions are being tested in trial NCT07298382?

The interventions under investigation include: Blue Light Therapy (DEVICE).

Who is sponsoring clinical trial NCT07298382?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07298382 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07298382, the US trial registry maintained by the National Library of Medicine. NCT07298382 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.